Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens

Zika virus (ZIKV) is a major public health concern due to its overwhelming spread into the Americas. Currently, there are neither licensed vaccines nor antiviral therapies available for the treatment of ZIKV. We aimed to identify and rationally optimize effective therapeutic regimens for ZIKV by eva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Pires de Mello, Camilly P., Tao, Xun, Kim, Tae Hwan, Bulitta, Jürgen B., Rodriquez, Jaime L., Pomeroy, Justin J., Brown, Ashley N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740374/
https://ncbi.nlm.nih.gov/pubmed/29109164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01983-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados